dexmedetomidine
Ma sedation
Approved small_molecule active
Quick answer
dexmedetomidine for Postoperative Cognitive Dysfunction is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Postoperative Cognitive Dysfunction
- Phase
- Approved
- Modality
- small_molecule
- Status
- active